These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 30571459)

  • 21. Lipoprotein particle profiles compared with standard lipids in association with coronary artery calcification in the general Japanese population.
    Hisamatsu T; Fujiyoshi A; Miura K; Ohkubo T; Kadota A; Kadowaki S; Kadowaki T; Yamamoto T; Miyagawa N; Zaid M; Torii S; Takashima N; Murakami Y; Okamura T; Horie M; Ueshima H;
    Atherosclerosis; 2014 Oct; 236(2):237-43. PubMed ID: 25105580
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Monocyte-to-High-Density Lipoprotein Ratio Is Associated with Systemic Inflammation, Insulin Resistance, and Coronary Subclinical Atherosclerosis in Psoriasis: Results from 2 Observational Cohorts.
    Berna-Rico E; Abbad-Jaime de Aragon C; Ballester-Martinez A; Perez-Bootello J; Solis J; Fernandez-Friera L; Llamas-Velasco M; Castellanos-Gonzalez M; Barderas MG; Azcarraga-Llobet C; Garcia-Mouronte E; de Nicolas-Ruanes B; Naharro-Rodriguez J; Jaen-Olasolo P; Gelfand JM; Mehta NN; Gonzalez-Cantero A
    J Invest Dermatol; 2024 Sep; 144(9):2002-2012.e2. PubMed ID: 38460808
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of Psoriasis With Biologic Therapy Is Associated With Improvement of Coronary Artery Plaque Lipid-Rich Necrotic Core: Results From a Prospective, Observational Study.
    Choi H; Uceda DE; Dey AK; Abdelrahman KM; Aksentijevich M; Rodante JA; Elnabawi YA; Reddy A; Keel A; Erb-Alvarez J; Teague H; Playford MP; Zhou W; Chen MY; Gelfand JM; Bluemke DA; Buckler A; Mehta NN
    Circ Cardiovasc Imaging; 2020 Sep; 13(9):e011199. PubMed ID: 32927971
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association Among Noncalcified Coronary Burden, Fractional Flow Reserve, and Myocardial Injury in Psoriasis.
    Zhou W; Abdelrahman KM; Dey AK; Reddy A; Uceda DE; Lateef SS; Elnabawi YA; Anzenberg P; Al Najafi M; Rodante JA; Keel A; Ortiz J; Teague HL; Erb-Alvarez J; Singh D; Joshi AA; Playford MP; Chen MY; Gelfand JM; Remaley AT; Bluemke DA; Mehta NN
    J Am Heart Assoc; 2020 Nov; 9(22):e017417. PubMed ID: 33170072
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential associations between blood biomarkers of inflammation, oxidation, and lipid metabolism with varying forms of coronary atherosclerotic plaque as quantified by coronary CT angiography.
    Bamberg F; Truong QA; Koenig W; Schlett CL; Nasir K; Butler J; Kurtz E; Nikolaou K; Hoffmann U; Januzzi JL
    Int J Cardiovasc Imaging; 2012 Jan; 28(1):183-92. PubMed ID: 21222039
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Accumulation of oxidized low-density lipoprotein in psoriatic skin and changes of plasma lipid levels in psoriatic patients.
    Tekin NS; Tekin IO; Barut F; Sipahi EY
    Mediators Inflamm; 2007; 2007():78454. PubMed ID: 17497039
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Psoriasis decreases the anti-oxidation and anti-inflammation properties of high-density lipoprotein.
    He L; Qin S; Dang L; Song G; Yao S; Yang N; Li Y
    Biochim Biophys Acta; 2014 Dec; 1841(12):1709-15. PubMed ID: 25240836
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Myeloperoxidase-oxidized high density lipoprotein impairs atherosclerotic plaque stability by inhibiting smooth muscle cell migration.
    Zhou B; Zu L; Chen Y; Zheng X; Wang Y; Pan B; Dong M; Zhou E; Zhao M; Zhang Y; Zheng L; Gao W
    Lipids Health Dis; 2017 Jan; 16(1):3. PubMed ID: 28069011
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dyslipidaemia & oxidative stress in patients of psoriasis: Emerging cardiovascular risk factors.
    Asha K; Singal A; Sharma SB; Arora VK; Aggarwal A
    Indian J Med Res; 2017 Dec; 146(6):708-713. PubMed ID: 29664028
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum active 1,25(OH)
    Playford MP; Dey AK; Zierold C; Joshi AA; Blocki F; Bonelli F; Rodante JA; Harrington CL; Rivers JP; Elnabawi YA; Chen MY; Ahlman MA; Teague HL; Mehta NN
    Atherosclerosis; 2019 Oct; 289():44-50. PubMed ID: 31450013
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relation of Plasma Lipoprotein(a) to Subclinical Coronary Plaque Volumes, Three-Vessel and Left Main Coronary Disease, and Severe Coronary Stenoses in Apparently Healthy African-Americans With a Family History of Early-Onset Coronary Artery Disease.
    Kral BG; Kalyani RR; Yanek LR; Vaidya D; Fishman EK; Becker DM; Becker LC
    Am J Cardiol; 2016 Sep; 118(5):656-61. PubMed ID: 27530333
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relations between metabolic syndrome, oxidative stress and inflammation and cardiovascular disease.
    Holvoet P
    Verh K Acad Geneeskd Belg; 2008; 70(3):193-219. PubMed ID: 18669160
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Complex association of apolipoprotein E-containing HDL with coronary artery disease burden in cardiovascular disease.
    Sorokin AV; Patel N; Abdelrahman KM; Ling C; Reimund M; Graziano G; Sampson M; Playford MP; Dey AK; Reddy A; Teague HL; Stagliano M; Amar M; Chen MY; Mehta NN; Remaley AT
    JCI Insight; 2022 May; 7(10):. PubMed ID: 35389891
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase.
    Aviram M; Rosenblat M; Bisgaier CL; Newton RS; Primo-Parmo SL; La Du BN
    J Clin Invest; 1998 Apr; 101(8):1581-90. PubMed ID: 9541487
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heritability of Biomarkers of Oxidized Lipoproteins: Twin Pair Study.
    Rao F; Schork AJ; Maihofer AX; Nievergelt CM; Marcovina SM; Miller ER; Witztum JL; O'Connor DT; Tsimikas S
    Arterioscler Thromb Vasc Biol; 2015 Jul; 35(7):1704-11. PubMed ID: 25953646
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of neutrophil-to-lymphocyte ratio with non-calcified coronary artery burden in psoriasis: Findings from an observational cohort study.
    Dey AK; Teague HL; Adamstein NH; Rodante JA; Playford MP; Chen MY; Bluemke DA; Gelfand JM; Ridker PM; Mehta NN
    J Cardiovasc Comput Tomogr; 2021; 15(4):372-379. PubMed ID: 33390348
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High density lipoprotein proteome is associated with cardiovascular risk factors and atherosclerosis burden as evaluated by coronary CT angiography.
    Gordon SM; Chung JH; Playford MP; Dey AK; Sviridov D; Seifuddin F; Chen YC; Pirooznia M; Chen MY; Mehta NN; Remaley AT
    Atherosclerosis; 2018 Nov; 278():278-285. PubMed ID: 30347343
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lipoprotein redox status evaluation as a marker of cardiovascular disease risk in patients with inflammatory disease.
    Ungurianu A; Margină D; Grădinaru D; Băcanu C; Ilie M; Tsitsimpikou C; Tsarouhas K; Spandidos DA; Tsatsakis AM
    Mol Med Rep; 2017 Jan; 15(1):256-262. PubMed ID: 27909725
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of Lipoprotein Composition and Function in Pediatric Psoriasis Reveals a More Atherogenic Profile.
    Tom WL; Playford MP; Admani S; Natarajan B; Joshi AA; Eichenfield LF; Mehta NN
    J Invest Dermatol; 2016 Jan; 136(1):67-73. PubMed ID: 26763425
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improved identification of patients with coronary artery disease by the use of new lipid and lipoprotein biomarkers.
    Johnston N; Jernberg T; Lagerqvist B; Siegbahn A; Wallentin L
    Am J Cardiol; 2006 Mar; 97(5):640-5. PubMed ID: 16490429
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.